Valproic Acid Capsule
Product Images NDC 43353-085

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Valproic Acid (NDC 43353-085). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 250mg (43353 0085 53)

Label for Valproic Acid 250 mg capsules, containing 90 capsules per bottle. The label states storage instructions, manufacturer information listing Catalept Pharma Solutions Inc in St. Petersburg, FL, and repackager Aphena Pharma Solutions - Tennessee, LLC in Cookeville, TN. It indicates the product is by prescription only.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Chemical Structure (Valproic 01)

Chemical structure of valproic acid showing its molecular composition and arrangement, including carbon, hydrogen, and oxygen atoms. The diagram depicts the chemical bonds and functional groups characteristic of valproic acid.*

FDA Label Image

Figure 1 (Valproic 02)

A cumulative percentage plot comparing the percentage reduction in CPS Rate between patients taking divalproex sodium delayed-release tablets USP and placebo. The y-axis shows the percent reduction in CPS Rate from -100% to 100%, with labels indicating improvement and worsening; the x-axis shows the percentage of patients from 0 to 100%. The solid line represents divalproex sodium delayed-release tablets, and the dotted line represents placebo, illustrating better improvement with the active drug.*

FDA Label Image

Figure 2 (Valproic 03)

A line graph showing percentage reduction in CPS rate versus percentage of patients for valproic acid doses. The y-axis represents percent reduction in CPS rate ranging from -100% to 100%, with labels indicating improvement and worsening. The x-axis shows percent of patients from 100 to 0. Two lines compare high dose (solid) and low dose (dashed).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.